[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100629398":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":20,"locations":26,"responsibleParty":45,"collaborators":10,"id":47,"slug":10,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":10,"eligibilityCriteria":52,"healthyVolunteers":48,"sex":53,"minAge":54,"maxAge":10,"enrollmentInfo":55,"targetDuration":10,"studyType":58,"phases":10,"briefSummary":59,"conditions":60,"keywords":10,"overallStatus":62,"whyStopped":10,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"Steno Diabetes Center Copenhagen","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Cohort of 780G users",null,"Cohort of 780G users who previously participated in the Steno780G trial",[13],"Device: 780G AID pump",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DEVICE","780G AID pump","Long term follow-up",[9],[21],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Merete Christensen, MD, PhD","CONTACT","+45 29429113","merete.bechmann.christensen@regionh.dk",[27],{"facility":5,"status":10,"city":28,"state":10,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"Herlev","2730","Denmark","DK",{"type":33,"coordinates":34},"Point",[35,36],12.43998,55.72366,{"lat":36,"lon":35},[39,40,42],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},{"name":22,"role":41,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"name":43,"role":44,"phone":10,"phoneExt":10,"email":10},"Kirsten Norgaard, Professor","SUB_INVESTIGATOR",{"type":46,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100629398",false,"NCT07474155","Steno780G Follow-up Study","Advanced Hybrid Closed-Loop Treatment in Adults With Type 1 Diabetes Not Meeting Glycaemic Targets - The Steno780G Follow-up Study","Inclusion Criteria:\n\n* Previous participation in the Steno780G study\n\nExclusion Criteria:\n\n* Lack of compliance with key study procedures at the discretion of the investigator.","ALL","18 Years",{"count":56,"type":57},40,"ESTIMATED","OBSERVATIONAL","Automated insulin delivery systems, also known as closed-loop systems, have shown to improve TIR, TAR, and TBR compared with insulin pump and CGM systems that cannot automatically dose insulin. Only few studies have described long-term use of AID systems over several years. Real-world studies suggest that the beneficial effects of AID systems on glycemic outcomes are sustained over time; however, a modest increase in body weight has been observed in some users, raising concerns about the metabolic trade-offs of improved glycemia. We aim to explore wether the improvements in glycemic outcomes and treatment satisfaction achieved with AID systems remain stable over multiple years, and secondly, if long-term treatment with AID systems may be associated with an increase in body weight.",[61],"Type 1 Diabetes","NOT_YET_RECRUITING","2026-03-10",{"date":65,"type":66},"2026-03-16","ACTUAL",{"date":68,"type":57},"2026-03",{"date":70,"type":57},"2026-10",{"name":5,"class":6},1]